Elísio Costa Selected Research

Hypertension (High Blood Pressure)

4/2016	Impaired renal endothelial nitric oxide synthase and reticulocyte production as modulators of hypertension induced by rHuEPO in the rat.
3/2016	Renal risk-benefit determinants of recombinant human erythropoietin therapy in the remnant kidney rat model - hypertension, anaemia, inflammation and drug dose.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elísio Costa Research Topics

Disease

17	Inflammation (Inflammations) 11/2017 - 01/2008
14	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2010
11	Chronic Renal Insufficiency 06/2016 - 01/2008
6	Anemia 06/2016 - 01/2010
4	Fibrosis (Cirrhosis) 05/2017 - 01/2015
4	Crigler-Najjar Syndrome 12/2015 - 01/2006
3	Frailty 11/2021 - 10/2020
3	Body Weight (Weight, Body) 06/2016 - 04/2016
3	Hypoxia (Hypoxemia) 04/2016 - 01/2015
3	Insulin Resistance 01/2016 - 01/2012
3	Gilbert Disease 03/2012 - 04/2002
3	Hereditary Spherocytosis 02/2011 - 03/2010
2	Renal Insufficiency (Renal Failure) 02/2024 - 01/2010
2	Weight Gain 01/2022 - 11/2016
2	Chronic Disease (Chronic Diseases) 10/2020 - 09/2018
2	Hemolysis 11/2018 - 12/2014
2	Overweight 11/2017 - 01/2013
2	Hypertension (High Blood Pressure) 04/2016 - 03/2016
2	Obesity 01/2016 - 08/2014
2	Hyperbilirubinemia 12/2015 - 01/2006
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2015 - 08/2014
2	Arteriovenous Fistula 05/2014 - 10/2013
2	Lymphopenia (Lymphocytopenia) 07/2008 - 05/2008
1	Death (Near-Death Experience) 01/2024
1	Cognitive Dysfunction 01/2024
1	Asthma (Bronchial Asthma) 01/2023
1	COVID-19 01/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 10/2018
1	Thrombosis (Thrombus) 10/2018
1	Drug-Related Side Effects and Adverse Reactions 09/2018
1	Iron Overload 05/2016
1	Pediatric Obesity 08/2014
1	Iron Deficiencies 01/2013
1	Dyslipidemias (Dyslipidemia) 01/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2012
1	Protein Deficiency 06/2010
1	Hemolytic Anemia 06/2010
1	Polycythemia (Erythrocytosis) 01/2010
1	Hypertrophy 01/2010
1	Tachycardia (Tachyarrhythmias) 01/2010

Drug/Important Bio-Agent (IBA)

12	Erythropoietin FDA Link 06/2016 - 01/2008
9	IronIBA 11/2017 - 01/2008
5	BilirubinIBA 01/2015 - 03/2010
4	HepcidinsIBA 11/2017 - 01/2008
4	Proteins (Proteins, Gene)FDA Link 12/2015 - 01/2008
4	AdiponectinIBA 08/2014 - 10/2012
3	C-Reactive ProteinIBA 01/2016 - 01/2015
3	LipidsIBA 01/2016 - 10/2012
3	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 12/2015 - 01/2006
3	Interleukin-6 (Interleukin 6)IBA 04/2015 - 05/2008
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 11/2016
2	Uridine Diphosphate (UDP)IBA 12/2015 - 04/2002
2	oxidized low density lipoproteinIBA 01/2015 - 10/2012
2	Transferrin (beta 2 Transferrin)IBA 01/2015 - 01/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2013 - 01/2012
2	Membrane Proteins (Integral Membrane Proteins)IBA 06/2010 - 01/2008
2	bilirubin glucuronoside glucuronosyltransferaseIBA 01/2006 - 11/2005
1	PotassiumIBA 01/2022
1	Phosphorus (Red Phosphorus)IBA 01/2022
1	2,2'-azobis(2-amidinopropane) (ABAP)IBA 11/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2018
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 10/2018
1	salicylhydroxamic acid (SHAM)IBA 06/2016
1	Pancreatic Elastase (Elastase)IBA 04/2016
1	Saline SolutionIBA 04/2016
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 04/2016
1	AdipokinesIBA 01/2016
1	AntibodiesIBA 12/2015
1	InterleukinsIBA 01/2015
1	Iron-Regulatory Proteins (Iron-Responsive Element Binding Proteins)IBA 12/2014
1	Irritants (Vesicants)IBA 12/2014
1	Biocompatible Materials (Biomaterials)IBA 12/2014
1	zirconium oxide (zirconia)IBA 04/2014
1	Cell-Free Nucleic AcidsIBA 10/2013
1	S 27IBA 10/2013
1	Lipoprotein(a)IBA 10/2012
1	Apoprotein(a) (Apolipoprotein (a))IBA 10/2012
1	Apolipoproteins B (ApoB)IBA 01/2012
1	Apolipoproteins AIBA 01/2012
1	ApolipoproteinsIBA 01/2012
1	Insulin (Novolin)FDA Link 01/2012
1	Triglycerides (Triacylglycerol)IBA 01/2012
1	Hemoglobins (Hemoglobin)IBA 02/2011
1	AnkyrinsIBA 06/2010
1	SpectrinIBA 06/2010
1	HematinicsIBA 01/2010
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010
1	CatecholaminesIBA 01/2010

Therapy/Procedure

17	Therapeutics 02/2024 - 01/2008
14	Renal Dialysis (Hemodialysis) 01/2022 - 01/2008
4	Hemodiafiltration 09/2016 - 05/2014
4	Nephrectomy 06/2016 - 01/2015
3	Polypharmacy 01/2021 - 09/2018
2	Blood Vessel Prosthesis 05/2017 - 11/2016
1	Palliative Care (Palliative Therapy) 01/2024
1	Length of Stay 01/2023
1	Diet Therapy (Therapy, Diet) 01/2022
1	Activities of Daily Living (ADL) 09/2018
1	Central Venous Catheters 05/2014
1	Catheters 10/2013